Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

EJB Talks: Alumnus Helps Rethink Jersey City’s Public Spaces

Alumnus Helps Rethink Jersey City's Public Spaces: A Conversation with Barkha Patel MCRP '15 Dean Stuart Shapiro talks to alumnus Barkha Patel, MCRP '15 this week on EJB Talks. Initially a sociology undergraduate at Rutgers, Barkha discusses how a chance visit by Dean...

NJSPL Report: Equity Initiatives in the United States

Report Release: Equity Initiatives in the United States Read Report The New Jersey State government proactively advances equity through its Office of Equity in the Office of the Governor, and through budget initiatives such as the “Cover all Kids” program ensuring...

Adrian Ponichtera is recipient of Ververides Scholarship

Adrian Ponichtera (MCRP '26) is the recipient of the New Jersey County Planners Association's George Ververides Honorary Scholarship. The scholarship is open to New Jersey residents entering their third or fourth year of undergraduate study or advanced degrees at a...

Bhuyan & Broom Publish New Healthcare Management Textbook

  Soumitra Bhuyan, Executive Director of Health Administration Programs and Associate Professor at Rutgers University-New Brunswick’s Edward J. Bloustein School of Planning and Public Policy, is the co-editor of a new textbook Fundamentals of Healthcare...

BEAT Students Participate in PATH Track Tunnel Tour

Graduate and undergraduate students who are part of the student group Bloustein Enthusiasts and Advocates for Transportation (BEAT) took part in an exclusive after-hours PATH (Port Authority Trans-Hudson) tour on Thursday, November 20 through Friday, November 21. The...